Accumulated seizure burden predicts neurodevelopmental outcome at 36 months of age in patients with tuberous

S Katie Z Ihnen1,2, Samuel Alperin3,4, Jamie K Capal5

  • 1Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Epilepsia
|October 29, 2024
PubMed

Insights

In tuberous sclerosis complex (TSC), accumulated seizure burden, not seizure onset age, best predicts neurodevelopmental outcomes by 36 months. Aggressive seizure management in early childhood is crucial for optimizing cognitive function in TSC patients.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Genetics

Background:

  • Tuberous sclerosis complex (TSC) frequently involves epilepsy and intellectual disability.
  • Early childhood seizures and neurodevelopmental deficits are correlated in TSC, but the specific impact of seizure timing and burden is unclear.

Purpose of the Study:

  • To investigate the distinct effects of age at seizure onset and accumulated seizure burden on neurodevelopmental outcomes in infants and young children with TSC.
  • To identify predictive biomarkers for neurodevelopmental trajectories in TSC.

Main Methods:

  • Analysis of seizure diaries, serial neurodevelopmental testing, and brain MRI in 129 TSC patients (0-36 months).
  • Machine learning applied to identify and track neurodevelopmental subgroups at 12 and 36 months.
  • Logistic regression used to assess candidate biomarkers (seizure onset age, seizure burden, tuber volume, sex, prior test scores) for predicting 36-month neurodevelopmental outcomes.

Main Results:

  • Two neurodevelopmental subgroups (higher and lower scoring) identified at 36 months, with 75% stability at 12 months.
  • Accumulated seizure burden showed the largest univariable effect on subgroup, followed by earlier test scores and tuber volume.
  • A multivariable model combining accumulated seizure burden and earlier test scores accurately predicted 36-month neurodevelopmental group (82% accuracy, AUC .86).

Conclusions:

  • Accumulated seizure burden is a more significant predictor of 36-month neurodevelopmental outcomes in young TSC patients than age at seizure onset.
  • These findings highlight the critical importance of aggressive seizure management in the first three years of life for TSC patients to improve both seizure control and cognitive function.
Abstract